Xilio Therapeutics, Inc. (XLO) Current Reports & Earnings Releases
Upcoming
- 2026-11-12 Earnings Release Estimated
| Filed | Form | Items | Filing |
|---|---|---|---|
| 2026-08-12 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2026-06-12 | 8-K | Officer / Director Changes, Shareholder Vote Results, Financial Statements & Exhibits | SEC |
| 2026-05-12 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2026-04-16 | 8-K | Officer / Director Changes, Financial Statements & Exhibits | SEC |
| 2026-03-23 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2026-03-12 | 8-K | Item 3.03, Charter Amendments, Financial Statements & Exhibits | SEC |
| 2026-03-09 | 8-K | Reg FD Disclosure, Financial Statements & Exhibits | SEC |
| 2026-02-24 | 8-K | Shareholder Vote Results | SEC |
| 2026-02-12 | 8-K | Material Agreement, Reg FD Disclosure, Financial Statements & Exhibits | SEC |
| 2026-01-08 | 8-K | Results of Operations, Officer / Director Changes, Financial Statements & Exhibits | SEC |
| 2026-01-05 | 8-K | Reg FD Disclosure, Financial Statements & Exhibits | SEC |
| 2025-11-25 | 8-K | Officer / Director Changes, Shareholder Vote Results, Financial Statements & Exhibits | SEC |
| 2025-11-13 | 8-K | Results of Operations | SEC |
| 2025-11-07 | 8-K | Reg FD Disclosure, Financial Statements & Exhibits | SEC |
| 2025-10-03 | 8-K | Listing Notice | SEC |
| 2025-09-09 | 8-K | Other Events, Financial Statements & Exhibits | SEC |
| 2025-08-28 | 8-K | Listing Notice | SEC |
| 2025-08-14 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2025-06-12 | 8-K | Shareholder Vote Results | SEC |
| 2025-06-10 | 8-K | Officer / Director Changes | SEC |
| 2025-06-03 | 8-K | Material Agreement, Reg FD Disclosure, Other Events, Financial Statements & Exhibits | SEC |
| 2025-06-02 | 8-K | Reg FD Disclosure, Other Events, Financial Statements & Exhibits | SEC |
| 2025-05-08 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2025-04-08 | 8-K | Listing Notice | SEC |
| 2025-03-11 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2025-03-11 | 8-K | Material Agreement, Financial Statements & Exhibits | SEC |
| 2025-02-12 | 8-K | Material Agreement, Unregistered Sales, Reg FD Disclosure, Other Events, Financial Statements & Exhibits | SEC |
| 2025-01-21 | 8-K | Reg FD Disclosure, Other Events, Financial Statements & Exhibits | SEC |
| 2024-12-19 | 8-K | Unregistered Sales, Reg FD Disclosure, Other Events, Financial Statements & Exhibits | SEC |
| 2024-11-07 | 8-K | Results of Operations, Reg FD Disclosure, Other Events, Financial Statements & Exhibits | SEC |
| 2024-09-13 | 8-K | Listing Notice | SEC |
| 2024-08-08 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2024-06-17 | 8-K | Shareholder Vote Results | SEC |
| 2024-06-13 | 8-K | Officer / Director Changes | SEC |
| 2024-05-14 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2024-04-01 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2024-03-28 | 8-K | Material Agreement, Results of Operations, Item 2.05, Unregistered Sales, Reg FD Disclosure, Other Events, Financial Statements & Exhibits | SEC |
| 2024-03-28 | 8-K | Other Events | SEC |
| 2024-01-19 | 8-K | Listing Notice | SEC |
| 2024-01-03 | 8-K | Officer / Director Changes, Financial Statements & Exhibits | SEC |
Sourced from SEC EDGAR 8-K/6-K filings. 8-K is the current-report form for US domestic issuers (Item 2.02 = earnings release); 6-K is the equivalent for foreign private issuers, including ADRs. Originals live on sec.gov.